Beta Bionics closes upsized IPO of 13.8M shares at $17.00, raises $229.1M

Beta Bionics, Inc.

IPO of 13,800,000 shares at $17.00/share, including full exercise of underwriters' option for 1,800,000 additional shares.
Gross proceeds to Beta Bionics from IPO total $212.1M; combined with concurrent private placement, aggregate proceeds $229.1M.
Private placement: 1,000,000 shares sold to existing investor at IPO price of $17.00/share.
Shares began trading on Nasdaq Global Market on January 30, 2025 under ticker BBNX.
Lead bookrunners: BofA Securities, Piper Sandler, and Leerink Partners; Stifel bookrunner; Lake Street co-manager.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.